Australian M&A and equity raisings

2,041 deals since January 2025, with sources and adviser credits where available · as at 20 Nov 2026 · Venture rounds

Deal size
Custom range

9 deals · A$169mdisclosed · Medtech · Clear

Columns
Australian M&A deals and equity raisings
Date Target Vendor Acquirer Type Status Value A$m Sector Advisers
Oct 2026 Heidi –BlackbirdStakeCompleted–Medtech Ashurst Perkins Coie (sell-side)
Sep 2026 Microba Life Sciences –Genetic SignaturesSchemeAnnounced–Medtech Latimer Partners (sell-side)Thomsons (sell-side)AE Advisors (buy-side)Gadens (buy-side)
May 2026 Kyra flow products Telstra HealthAlcidion GroupAsset saleAnnounced3.0Medtech Henslow (buy-side)Arnold Bloch Leibler (buy-side)
Feb 2026 SDI Jeffery James CheethamBeijing Guoci Kebo Technology Co.SchemeCompleted166.4Medtech Houlihan Lokey (sell-side)DLA Piper (sell-side)Rothschild & Co (buy-side)Herbert Smith Freehills Kramer (buy-side)
Feb 2026 SAVI Surgical –Smartways LogisticsAcquisitionCompleted–Medtech Record Point (sell-side)
Feb 2026 Southern Cross Diagnostics –Novacyt SAAcquisitionCompleted–Medtech Hamilton Locke (buy-side)Addleshaw Goddard (buy-side)Frieh, Brault & Associés (buy-side)
Jul 2025 Bluechiip Limited (ASX:BCT) and its US-based subsidiary, the Bluechiip Group –CryonixAsset saleAnnounced–Medtech Moray & Agnew (sell-side)Mills Oakley (buy-side)
Jun 2025 Lyrebird Health ––StakeCompleted–Medtech Herbert Smith Freehills Kramer (sell-side)Corrs Chambers Westgarth (sell-side)
Aug 2024 Evolution Surgical –Quadrant Private EquityStakeAnnounced–Medtech Herbert Smith Freehills Kramer (buy-side)Boston Consulting Group (buy-side)KPMG (buy-side)GreenMount (buy-side)

Deals come from ASX announcements, scheme booklets, prospectuses, the advisers' own deal announcements and the press. How the data is built